Edition:
United Kingdom

Aridis Pharmaceuticals Inc (ARDS.OQ)

ARDS.OQ on NASDAQ Stock Exchange Capital Market

9.10USD
3:41pm BST
Change (% chg)

$-0.60 (-6.19%)
Prev Close
$9.70
Open
$9.28
Day's High
$9.28
Day's Low
$9.04
Volume
1,029
Avg. Vol
1,503
52-wk High
$13.85
52-wk Low
$7.59

About

Aridis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs), to treat infections. mAbs represents treatment approach that enables the human immune system to fight infections and are designed to overcome the... (more)

Overall

Beta: --
Market Cap(Mil.): $76.21
Shares Outstanding(Mil.): 8.11
Dividend: --
Yield (%): --

Financials

  ARDS.OQ Industry Sector
P/E (TTM): -- 97.03 53.45
EPS (TTM): -2.92 -- --
ROI: -89.10 7.44 11.71
ROE: -- 7.90 16.35

Earnings vs. Estimates